×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BRKR – bruker corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BRKR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/1
07:00 am
brkr
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
Low
Report
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
3/31
01:07 pm
brkr
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
Low
Report
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
3/30
12:44 pm
brkr
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
3/30
06:18 am
brkr
Bruker (BRKR) had its "sell (d+)" rating reaffirmed by Weiss Ratings.
Low
Report
Bruker (BRKR) had its "sell (d+)" rating reaffirmed by Weiss Ratings.
3/23
08:31 am
brkr
Here's Why Bruker's (BRKR) Positive Momentum Returned in Q4 [Yahoo! Finance]
Low
Report
Here's Why Bruker's (BRKR) Positive Momentum Returned in Q4 [Yahoo! Finance]
2/25
07:00 am
brkr
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
Low
Report
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
2/24
07:00 am
brkr
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
Low
Report
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
2/23
07:00 am
brkr
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
Medium
Report
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
07:00 am
brkr
Form 8-K BRUKER CORP For: Apr 01
Low
Report
Form 8-K BRUKER CORP For: Apr 01
3/26
04:44 pm
brkr
Form SCHEDULE 13G/A BRUKER CORP Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A BRUKER CORP Filed by: VANGUARD GROUP INC
3/16
04:15 pm
brkr
Form 4 BRUKER CORP For: Mar 13 Filed by: Munch Mark
Low
Report
Form 4 BRUKER CORP For: Mar 13 Filed by: Munch Mark
3/13
04:19 pm
brkr
Form 144 BRUKER CORP Filed by: Munch Mark
Low
Report
Form 144 BRUKER CORP Filed by: Munch Mark
3/6
11:45 am
brkr
Form SCHEDULE 13G/A BRUKER CORP Filed by: ORBIS INVESTMENT MANAGEMENT LTD
Low
Report
Form SCHEDULE 13G/A BRUKER CORP Filed by: ORBIS INVESTMENT MANAGEMENT LTD
2/27
04:05 pm
brkr
Form 10-K BRUKER CORP For: Dec 31
Low
Report
Form 10-K BRUKER CORP For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/31
Q3/2019 9/30/2019 EPS 0.430 ZacksConsensus 0.380 ActVsEst 0.050 - Beat
12.6%
3/25 Form 4 BRUKER CORP For: Mar 24 Filed by: LAUKIEN FRANK H 9.8%
4/2 Bruker Co. (NASDAQ: BRKR) was downgraded by analysts at Wolfe Research from a "market perform" rating to an "underperform" rating. 6.5%
3/24 Bruker Announces Launch of CE-IVD Marked genesig® Assay Kit for the Detection of the SARS-CoV-2 Virus 5.9%
3/30 Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at SVB Leerink LLC from $58.00 to $46.00. They now have an "outperform" rating on the stock. 5.6%
8/6 Bruker Co. (NASDAQ: BRKR) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 4.6%
9/11 Bruker Launches Nanoscale Infrared Spectroscopy and Chemical Imaging SNOM/AFM Microscopy System with Broadband Femtosecond IR Laser 4.4%
4/22 Form DEF 14A BRUKER CORP For: May 21 4.3%
2/19 Bruker Co. (NASDAQ: BRKR) had its price target raised by analysts at Needham & Company LLC from $62.00 to $63.00. They now have a "strong-buy" rating on the stock. 2.9%
6/3 Form 4 BRUKER CORP For: Jun 03 Filed by: LAUKIEN FRANK H 2.1%
3/25 Form 4 BRUKER CORP For: Mar 24 Filed by: LAUKIEN FRANK H 9.8%
4/2 Bruker Co. (NASDAQ: BRKR) was downgraded by analysts at Wolfe Research from a "market perform" rating to an "underperform" rating. 6.5%
3/24 Bruker Announces Launch of CE-IVD Marked genesig® Assay Kit for the Detection of the SARS-CoV-2 Virus 5.9%
3/30 Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at SVB Leerink LLC from $58.00 to $46.00. They now have an "outperform" rating on the stock. 5.6%
8/6 Bruker Co. (NASDAQ: BRKR) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 4.6%
9/11 Bruker Launches Nanoscale Infrared Spectroscopy and Chemical Imaging SNOM/AFM Microscopy System with Broadband Femtosecond IR Laser 4.4%
4/22 Form DEF 14A BRUKER CORP For: May 21 4.3%
2/19 Bruker Co. (NASDAQ: BRKR) had its price target raised by analysts at Needham & Company LLC from $62.00 to $63.00. They now have a "strong-buy" rating on the stock. 2.9%
6/3 Form 4 BRUKER CORP For: Jun 03 Filed by: LAUKIEN FRANK H 2.1%
TOP News Decliners
3/31
Bruker Co. (NASDAQ: BRKR) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.
-12.0%
8/1 Form 8-K BRUKER CORP For: Aug 01 -11.6%
3/6 Investor Alert: Kaplan Fox Investigates Bruker Corporation -8.9%
3/20 Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Citigroup Inc from $52.00 to $40.00. They now have a "neutral" rating on the stock. -8.8%
11/4 Form 10-Q BRUKER CORP For: Sep 30 -4.1%
3/5 Bruker (BRKR) QEarnings Call Transcript [The Motley Fool] -4.1%
11/15 Bruker Corporation to Present at Investor Conferences -3.8%
8/4 Bruker Corp (BRKR) CEO Frank Laukien on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.7%
8/13 Form 4 BRUKER CORP For: Aug 09 Filed by: Munch Mark -3.5%
8/12 Bruker Announces Quarterly Dividend -3.0%
8/1 Form 8-K BRUKER CORP For: Aug 01 -11.6%
3/6 Investor Alert: Kaplan Fox Investigates Bruker Corporation -8.9%
3/20 Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Citigroup Inc from $52.00 to $40.00. They now have a "neutral" rating on the stock. -8.8%
11/4 Form 10-Q BRUKER CORP For: Sep 30 -4.1%
3/5 Bruker (BRKR) QEarnings Call Transcript [The Motley Fool] -4.1%
11/15 Bruker Corporation to Present at Investor Conferences -3.8%
8/4 Bruker Corp (BRKR) CEO Frank Laukien on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.7%
8/13 Form 4 BRUKER CORP For: Aug 09 Filed by: Munch Mark -3.5%
8/12 Bruker Announces Quarterly Dividend -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: